title: Patent watch: Stelara safe after IL-12 antibody dispute.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Harrison
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000378:metabolism*; D001666:Binding Sites, Antibody / Q000187:drug effects; D034462:Dissent and Disputes; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology* / Q000378:metabolism*; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018664:Interleukin-12; D000069549:Ustekinumab